Six weeks after birth, “Yangyang” — the first somatic cell–cloned cat in East China — is healthy and thriving. A research team from Yangzhou University, a global leader in veterinary science, has tackled the challenge of low cloning efficiency with an innovative in vivo maturation technique.
Combined with their latest breakthrough in gene editing, this advancement could pave the way for hypoallergenic cat breeds. Customized, allergy-free pets may soon become a reality — a purr-fect leap forward!
@ChinaScience @SmithsonianMag